Prostate Cancer - Results from #18920

Decision analysis of dutasteride use for patients with negative prostate biopsy - Abstract March 21, 2015

Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients - Abstract March 21, 2015

Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: Radical prostatectomy vs intensity-modulated radiotherapy with androgen deprivation therapy - Abstract March 21, 2015

Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African American, human immunodeficiency virus-infected patients - Abstract March 20, 2015

Shared decision making and use of decision aids for localized prostate cancer: Perceptions from radiation oncologists and urologists - Abstract March 20, 2015

Untreated Gleason grade progression on serial biopsies during prostate cancer active surveillance: Clinical course and pathological outcomes - Abstract March 20, 2015

An age-adjusted comorbidity index for prediction of long-term, other-cause mortality in men with prostate cancer - Abstract March 20, 2015

Patients with biopsy Gleason 9 and 10 prostate cancer have significantly worse outcomes compared with Gleason 8 disease - Abstract March 20, 2015

The role of magnetic resonance image-guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy - Abstract March 20, 2015

Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States - Abstract March 20, 2015

Time from first detectable PSA following radical prostatectomy to biochemical recurrence: A competing risk analysis - Abstract March 20, 2015

Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer - Abstract March 20, 2015

#EAU15 - Myriad announces Prolaris® test biopsy results from EMPATHY-P study at European Association of Urology annual meeting March 20, 2015

Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective? - Abstract March 20, 2015

Systematic review and meta-analysis of factors determining change to radical treatment in active surveillance for localized prostate cancer - Abstract March 20, 2015

Robotic-assisted radical prostatectomy - Abstract March 20, 2015

18F-fluorometilcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: Which is better? A literature revision March 20, 2015

Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® Soluble focal treatment for localized prostate cancer - Abstract March 19, 2015

Extracapsular extension in prostate cancer: Added value of diffusion-weighted MRI in patients with equivocal findings on t2-weighted imaging - Abstract March 19, 2015

African Americans' perceptions of prostate-specific antigen prostate cancer screening - Abstract March 19, 2015

Page 947 of 1458